Clinical Trials and Real-World Evidence in Cardiovascular Pharmacology

This track focuses on evaluating cardiovascular medicines through clinical research and real-world data. It covers trial design, efficacy endpoints, safety assessment, patient-reported outcomes, registries, and observational studies. Real-world evidence can complement randomized clinical trials and reveal treatment patterns in diverse populations. Innovative research methodologies can accelerate evidence-based cardiovascular care.

    Related Conference of Clinical Trials and Real-World Evidence in Cardiovascular Pharmacology

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Clinical Trials and Real-World Evidence in Cardiovascular Pharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in